arrow_back Back to App

Streamlining Pancreatic Islet Cell Transplantation for Diabetes Patients.

This Act changes how pancreatic islet cells, harvested from deceased donors and used to treat diabetes, are regulated. Instead of being classified as drugs or biological products, they will be regulated as organs for transplantation. This aims to simplify procedures and potentially increase the availability of this life-saving therapy for patients with severe Type 1 diabetes.
Key points
Pancreatic islet cells (used for diabetes treatment) are now legally treated as organs, not drugs or biological products.
This change is intended to speed up and simplify access to these cell transplants for patients by bypassing lengthy drug approval processes.
The Secretary of Health and Human Services must update regulations within one year to implement this new classification.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_2205
Sponsor: Sen. Lee, Mike [R-UT]
Process start date: 2023-06-22
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

ISLET Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_2205.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-06-22.

What are the main provisions?

Key points include:

  • Pancreatic islet cells (used for diabetes treatment) are now legally treated as organs, not drugs or biological products.
  • This change is intended to speed up and simplify access to these cell transplants for patients by bypassing lengthy drug approval processes.
  • The Secretary of Health and Human Services must update regulations within one year to implement this new classification.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Lee, Mike [R-UT].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health